|1.||Carrier, Lucie: 1 article (07/2013)|
|2.||Braren, Ingke: 1 article (07/2013)|
|3.||Mearini, Giulia: 1 article (07/2013)|
|4.||Behrens-Gawlik, Verena: 1 article (07/2013)|
|5.||Garcia, Luis: 1 article (07/2013)|
|6.||Weinberger, Florian: 1 article (07/2013)|
|7.||Schlossarek, Saskia: 1 article (07/2013)|
|8.||Stimpel, Doreen: 1 article (07/2013)|
|9.||Lorain, Stéphanie: 1 article (07/2013)|
|10.||Gedicke-Hornung, Christina: 1 article (07/2013)|
|1.||Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
10/01/2002 - "In this study we have identified antisense oligoribonucleotides with which the skipping of 11 other Duchenne muscular dystrophy exons could be induced in cultured human muscle cells. "
05/01/2009 - "For subsets of Duchenne muscular dystrophy (DMD) mutations, antisense oligoribonucleotide (AON)-mediated exon skipping has proven to be efficacious in restoring the expression of dystrophin protein. "
10/01/2002 - "We recently showed that antisense oligoribonucleotide-mediated skipping of exon 46 efficiently induced dystrophin synthesis in cultured muscle cells from Duchenne muscular dystrophy patients carrying an exon 45 deletion. "
|2.||Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa)
10/01/2005 - "To investigate the role of Ras antisense oligoribonucleotide (ASODN) in multidrug resistance (MDR) of pancreatic carcinoma Pc-2 cells. "
10/01/2005 - "[Effects of Ras antisense oligoribonucleotide on multidrug resistance of pancreatic carcinoma Pc-2 cells]."
03/15/2002 - "Transfection of 2'-O-methoxyethyl-modified Hus1 antisense oligoribonucleotides into human H1299 nonsmall lung carcinoma cells was performed using Lipofectin as the carrier. "
|4.||beta-Thalassemia (Cooley's Anemia)
|5.||Heart Diseases (Heart Disease)